Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Luca Valenti, V. Borroni et al.|Journal of Hepatology|2020Cited by 361
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in womenAlessandro Cherubini, Luca Valenti, Mahnoosh Ostadreza et al.|Nature Medicine|2023Cited by 130
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver diseaseOveis Jamialahmadi, Stefano Romeo, Antonio De Vincentis et al.|Nature Medicine|2024Cited by 100
Rare ATG7 genetic variants predispose patients to severe fatty liver diseaseGuido Baselli, Marcello Dallio, Oveis Jamialahmadi et al.|Journal of Hepatology|2022Cited by 93
Genome-wide interaction study with body mass index identifies <i>CYP7A1</i> and <i>GIPR</i> as genetic modulators of metabolic dysfunction-associated steatotic liver diseaseOveis Jamialahmadi, Stefano Romeo|Clinical and Molecular Hepatology|2025Cited by 8